EX-99.1 2 w32638aexv99w1.htm SELECT MEDICAL CORPORATION PRESS RELEASE exv99w1
 

Exhibit 99.1
     
(NEWS RELEASE LOGO)
  (SELECT MEDICAL CORPORATION LOGO)
FOR IMMEDIATE RELEASE
  4716 Old Gettysburg Road
Mechanicsburg, PA 17055
Select Medical Corporation Announces Results for
Fourth Quarter and Year Ended December 31, 2006
     MECHANICSBURG, PENNSYLVANIA — March 28, 2007 — Select Medical Corporation (“Select”) today announced results for its fourth quarter and year ended December 31, 2006.
     On February 24, 2005, Select consummated a merger with a wholly-owned subsidiary of Select Medical Holdings Corporation (“Holdings”) pursuant to which Select became a wholly-owned subsidiary of Holdings. Holdings is owned by an investor group that includes Welsh, Carson, Anderson & Stowe IX, LP (“Welsh Carson”), Thoma Cressey Bravo (“Thoma Cressey”) and members of Select’s senior management. As a result of the merger, Select’s assets and liabilities have been adjusted to their fair value as of the closing. Select also experienced an increase in aggregate outstanding indebtedness as a result of financing transactions associated with the merger. Accordingly, amortization expense and interest expense are higher in periods following the merger. Additionally, certain costs associated with the merger are reflected in the 2005 income statement periods. As a result, the financial statements for the periods before and after the merger are not comparable in certain respects. For ease of comparison, the 2005 financial data presented represents the combination of the period before the Merger, January 1, 2005 through February 24, 2005 with the period subsequent to the Merger, February 25, 2005 through December 31, 2005.
     For the fourth quarter ended December 31, 2006, net operating revenues decreased 2.7% to $445.7 million compared to $458.0 million for the same quarter, prior year. Income from operations decreased 8.8% to $59.1 million compared to $64.8 million for the same quarter, prior year. Net income increased 29.7% to $32.8 million compared to $25.3 million for the same quarter, prior year. Additionally, net income before interest, income taxes, depreciation and amortization, income from discontinued operations, loss on early retirement of debt, merger related charges, stock compensation expense, long-term incentive compensation, other income and minority interest (“Adjusted EBITDA”) for the fourth quarter decreased 7.3% to $71.8 million compared to $77.4 million for the same quarter, prior year. A reconciliation of net income to Adjusted EBITDA is attached to this release.
     For the year ended December 31, 2006, net operating revenues decreased 0.4% to $1,851.5 million compared to $1,858.4 million for the prior year. Income from operations increased 116.5% to $257.9 million compared to $119.1 million for the prior year. Net income was $118.2 million compared to a net loss of $14.7 million for the prior year. Additionally, Adjusted EBITDA for the year ended December 31, 2006 decreased 6.5% to $308.3 million compared to $329.9 million for the prior year.

 


 

     On March 1, 2006, a subsidiary of Select sold all the issued and outstanding shares of Canadian Back Institute Limited (“CBIL”) for approximately C$89.8 million in cash (US $79.0 million). CBIL comprised Select’s entire Canadian operations. As a result of the sale, the operating results of CBIL have been reclassified and reported as discontinued operations for all reported periods, and its assets and liabilities have been reclassified as held for sale on Select’s December 31, 2005 balance sheet.
Specialty Hospitals
     At December 31, 2006, Select operated 92 long-term acute care hospitals and four acute medical rehabilitation hospitals. This compares to 97 long-term acute care hospitals and four acute medical rehabilitation hospitals operated at December 31, 2005. For the fourth quarter of 2006, net operating revenues for all of Select’s hospitals decreased 3.6% to $328.8 million compared to $341.1 million for the same quarter, prior year. Total patient days for the fourth quarter 2006 were 235,520, admissions were 9,546 and net revenue per patient day was $1,366. This compares to 245,165 days, 9,907 admissions and net revenue per patient day of $1,367 for the same quarter, prior year. For the hospitals opened or acquired as of January 1, 2005 and operated by Select throughout both periods, patient days in the fourth quarter of 2006 were 233,852 and admissions were 9,487, compared to 238,068 days and 9,662 admissions in the same quarter, prior year. Adjusted EBITDA for the segment decreased 10.7% to $65.1 million compared to $72.8 million for the same quarter, prior year. The Adjusted EBITDA margin for the segment was 19.8% for the fourth quarter of 2006, compared to 21.4% for the same quarter, prior year. The Adjusted EBITDA margin for the hospitals opened or acquired as of January 1, 2005 and operated by Select throughout both periods was 21.0% for the fourth quarter of 2006, compared to 21.5% for the same quarter, prior year.
     For the year ended December 31, 2006, net operating revenues for all of Select’s hospitals increased 0.4% to $1,378.5 million compared to $1,372.5 million for the prior year. Total patient days for the year ended December 31, 2006 were 969,590, admissions were 39,668 and net revenue per patient day was $1,392. This compares to 985,025 days, 39,963 admissions and net revenue per patient day of $1,370 for the prior year. For the hospitals opened or acquired as of January 1, 2005 and operated by Select throughout both periods, patient days for the year ended December 31, 2006 were 951,872 and admissions were 39,026, compared to 948,916 days and 38,707 admissions in the prior year. Adjusted EBITDA for the segment for the year ended December 31, 2006 decreased 8.1% to $283.3 million compared to $308.1 million for the prior year. The Adjusted EBITDA margin for the segment for the year ended December 31, 2006 was 20.5%, compared to 22.5% for the prior year. The Adjusted EBITDA margin for the hospitals opened or acquired as of January 1, 2005 and operated by Select throughout both periods was 21.6% for the year ended December 31, 2006, compared to 22.9% for the prior year.
Outpatient Rehabilitation
     At December 31, 2006, Select operated 544 outpatient clinics. This compares to 608 outpatient clinics at December 31, 2005. For the fourth quarter of 2006, net operating revenues were $116.4 million compared to $116.3 million for the same quarter, prior year. Adjusted EBITDA for the fourth quarter increased 17.4% to $15.9 million compared to $13.5 million for the same quarter, prior year. The Adjusted EBITDA margin for the quarter was 13.7% compared to 11.6% in the same quarter, prior year. Patient visits for the quarter were 711,163 compared to 776,463 for the same quarter, prior year. Net revenue per visit was $98 for the fourth quarter of 2006 compared to $90 for the same quarter, prior year.
     For the year ended December 31, 2006, net operating revenues declined 2.2% to $470.3 million compared to $480.7 million for the prior year. Adjusted EBITDA for the year ended December 31, 2006 declined 1.7% to $64.8 million compared to $66.0 million for the prior year. The Adjusted EBITDA margin for the year ended December 31, 2006 was 13.8% compared to 13.7% in the prior year. Patient

 


 

visits for the year ended December 31, 2006 were 2,972,243 compared to 3,308,620 for the prior year. Net revenue per visit was $94 for the year ended December 31, 2006 compared $89 for the prior year.
Agreement to Purchase HealthSouth Corporation Outpatient Rehabilitation Division
     On January 27, 2007, Select and HealthSouth Corporation (“HealthSouth”) entered into a Stock Purchase Agreement, pursuant to which Select agreed to acquire the outpatient rehabilitation division of HealthSouth for approximately $245.0 million. The purchase price is subject to adjustment based on the division’s net working capital on the closing date.
     The HealthSouth transaction, which is expected to close in the second quarter of 2007, is subject to a number of closing conditions, including receipt of regulatory approvals.
Agreement to Purchase Nexus Health Systems, Inc.
     On March 26, 2007, Select entered into a Stock Purchase Agreement with Nexus Health Systems, Inc. (“Nexus”), Neurobehavioral Management Services L.L.C., Nexus Health Inc. and the stockholders of Nexus Health Systems, Inc. to acquire substantially all of the assets of Nexus for approximately $49.0 million in cash plus the assumption of a capital lease. The purchase price is subject to adjustment based on Nexus’s net working capital, cash and indebtedness on the closing date.
     The Nexus transaction, which is expected to close in the second quarter of 2007, is subject to a number of closing conditions, including receipt of regulatory approvals.
Conference Call
     Select will host a conference call regarding its fourth quarter and full year results on Thursday, March 29, 2007, at 11:00 am EDT. The domestic dial in number for the call is 1-866-793-1343. The international dial in number is 1-703-639-1314.
* * * * *
     Select Medical Corporation is a leading operator of specialty hospitals in the United States. Select operates 89 long-term acute care hospitals in 26 states. Select operates four acute medical rehabilitation hospitals in New Jersey. Select is also a leading operator of outpatient rehabilitation clinics in the United States, with approximately 544 locations. Select also provides medical rehabilitation services on a contract basis at nursing homes, hospitals, assisted living and senior care centers, schools and worksites. Information about Select is available at http://www.selectmedicalcorp.com/
     Certain statements contained herein that are not descriptions of historical facts are “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to those discussed in filings made by Select with the Securities and Exchange Commission. Many of the factors that will determine Select’s future results are beyond the ability of management to control or predict. Readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. Select undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor inquiries:
Joel Veit, 717/972-1100

 


 

I. Condensed Consolidated Statements of Operations
(In thousands)
(unaudited)
For the Three Months Ended December 31, 2005 and 2006
                         
                    %  
    2005     2006     Change  
Net operating revenues
  $ 457,958     $ 445,742       (2.7 )%
 
                       
Costs and expenses:
                       
 
                       
Cost of services
    368,795       364,865       (1.1 )%
 
                       
General and administrative
    10,534       10,003       (5.0 )%
 
                       
Bad debt expense
    3,969       44       (98.9 )%
 
                       
Depreciation and amortization
    9,812       11,713       19.4 %
 
                 
 
                       
Income from operations
    64,848       59,117       (8.8 )%
 
                       
Other income
    2,360       448       (81.0 )%
Interest income
    256       555       116.8 %
Interest expense
    (23,631 )     (24,673 )     4.4 %
 
                 
 
                       
Income from continuing operations before minority interests and income taxes
    43,833       35,447       (19.1 )%
 
                       
Minority interests
    426       319       (25.1 )%
 
                 
 
                       
Income from continuing operations before income taxes
    43,407       35,128       (19.1 )%
 
                       
Income tax expense
    17,847       4,811       (73.0 )%
 
                 
 
                       
Income from continuing operations
    25,560       30,317       18.6 %
 
                       
Income (loss) from discontinued operations, net of tax
    (295 )     2,460       N/M  
 
                 
 
                       
Net income
  $ 25,265     $ 32,777       29.7 %
 
                 

 


 

II. Condensed Consolidated Statements of Operations
(In thousands)
(unaudited)
For the Years Ended December 31, 2005 and 2006
                                           
    Predecessor(1)       Successor(1)     Combined (2)     Successor (1)        
    Period from       Period from                    
    January 1       February 25                    
    through       through     Year Ended     Year Ended        
    February 24,       December     December 31,     December 31,        
    2005       31, 2005     2005     2006     % Change  
Net operating revenues
  $ 277,736       $ 1,580,706     $ 1,858,442     $ 1,851,498       (0.4 )%
 
                                         
Costs and expenses:
                                         
 
                                         
Cost of services
    244,321         1,244,361       1,488,682       1,484,632       (0.3 )%
 
                                         
General and administrative
    122,509         59,494       182,003       43,514       (76.1 )%
 
                                         
Bad debt expense
    6,588         18,213       24,801       18,810       (24.2 )%
 
                                         
Depreciation and amortization
    5,933         37,922       43,855       46,668       6.4 %
 
                               
Income (loss) from operations
    (101,615 )       220,716       119,101       257,874       116.5 %
 
                                         
Loss on early retirement of debt
    (42,736 )             (42,736 )           N/M  
Merger related charges
    (12,025 )             (12,025 )           N/M  
Other income
    267         3,018       3,285       1,366       (58.4 )%
Interest income
    523         767       1,290       1,293       0.2 %
Interest expense
    (4,651 )       (83,752 )     (88,403 )     (97,288 )     10.1 %
 
                               
Income (loss) from continuing operations before minority interests and income taxes
    (160,237 )       140,749       (19,488 )     163,245       N/M  
 
                                         
Minority interests
    330         1,776       2,106       1,414       (32.9 )%
 
                               
Income (loss) from continuing operations before income taxes
    (160,567 )       138,973       (21,594 )     161,831       N/M  
 
                                         
Income tax expense (benefit)
    (59,794 )       56,470       (3,324 )     56,089       N/M  
 
                               
Income (loss) from continuing operations
    (100,773 )       82,503       (18,270 )     105,742       N/M  
 
                                         
Income from discontinued operations, net of tax (includes pretax gain of $13,950 in 2006)
    522         3,072       3,594       12,478       247.2 %
 
                               
Net income (loss)
  $ (100,251 )     $ 85,575     $ (14,676 )   $ 118,220       N/M  
 
                               
 
(1)   On February 24, 2005, Select Medical Corporation (“Select”) merged with a subsidiary of Select Medical Holdings Corporation (“Holdings”) and became a wholly owned subsidiary of Holdings. Select’s financial position and results of operations prior to the Merger are presented separately in the consolidated financial statements as “Predecessor” financial statements, while the financial position and results of operations following the Merger are presented as “Successor” financial statements. Due to the revaluation of assets as a result of purchase accounting associated with the Merger, the pre-merger financial statements are not comparable with those after the Merger in certain respects.
 
(2)   Although the Predecessor and Successor results are not comparable by definition in certain respects due to the Merger and the resulting revaluation, for ease of comparison, the financial data for the period after the merger, February 25, 2005 through December 31, 2005 (Successor period), has been added to the financial data for the period from January 1, 2005 through February 24, 2005 (Predecessor period), to arrive at the combined year ended December 31, 2005. As a result of the Merger, interest expense, loss on early retirement of debt, merger related charges, stock compensation expense, long-term incentive compensation, depreciation and amortization have been impacted.

 


 

III. Condensed Consolidated Balance Sheets
(In thousands)
(unaudited)
                 
    December 31,     December 31,  
    2005     2006  
Assets
               
Cash
  $ 35,861     $ 81,600  
Restricted cash
    6,345       4,335  
Accounts receivable, net
    256,798       199,927  
Current deferred tax asset
    59,135       42,613  
Prepaid taxes
    4,110        
Current assets held for sale
    13,876        
Other current assets
    19,725       16,762  
 
           
Total Current Assets
    395,850       345,237  
Property and equipment, net
    248,541       356,336  
Goodwill
    1,305,210       1,323,572  
Other identifiable intangibles
    86,789       79,230  
Other assets held for sale
    61,388       4,855  
Other assets
    65,591       68,412  
 
           
Total Assets
  $ 2,163,369     $ 2,177,642  
 
           
Liabilities and Stockholder’s Equity
               
Payables and accruals
  $ 296,765     $ 297,698  
Income taxes payable
          1,937  
Current liabilities held for sale
    4,215        
Current portion of long term debt
    6,516       6,209  
 
           
Total Current Liabilities
    307,496       305,844  
Long term debt, net of current portion
    1,315,764       1,224,509  
Non-current deferred tax liability
    25,771       30,721  
Non-current liabilities held for sale
    3,817        
Minority interests
    4,356       2,566  
Stockholder’s equity
    506,165       614,002  
 
           
Total Liabilities and Stockholder’s Equity
  $ 2,163,369     $ 2,177,642  
 
           

 


 

IV. Key Statistics
(unaudited)
For the Three Months Ended December 31, 2005 and 2006
                         
                    %
    2005   2006   Change
Specialty Hospitals (a)
                       
 
                       
Number of hospitals — end of period
    101       96       (5.0 )%
 
                       
Net operating revenues (,000)
  $ 341,096     $ 328,775       (3.6 )%
 
                       
Number of patient days
    245,165       235,520       (3.9 )%
 
                       
Number of admissions
    9,907       9,546       (3.6 )%
 
                       
Net revenue per patient day (b)
  $ 1,367     $ 1,366       (0.1 )%
 
                       
Adjusted EBITDA (,000)
  $ 72,833     $ 65,067       (10.7 )%
 
                       
Adjusted EBITDA margin — all hospitals
    21.4 %     19.8 %     (7.5 )%
Adjusted EBITDA margin — same store hospitals (c)
    21.5 %     21.0 %     (2.3 )%
 
                       
Outpatient Rehabilitation (d)
                       
 
                       
Number of clinics — end of period
    608       544       (10.5 )%
 
                       
Net operating revenues (,000)
  $ 116,348     $ 116,365       0.0 %
 
                       
Number of visits
    776,463       711,163       (8.4 )%
 
                       
Revenue per visit (e)
  $ 90     $ 98       8.9 %
 
                       
Adjusted EBITDA (,000)
  $ 13,543     $ 15,903       17.4 %
 
                       
Adjusted EBITDA margin
    11.6 %     13.7 %     18.1 %
 
(a)   Specialty hospitals consist of long-term acute care hospitals and acute medical rehabilitation hospitals.
 
(b)   Net revenue per patient day is calculated by dividing specialty hospital patient service revenue by the total number of patient days.
 
(c)   Adjusted EBITDA margin — same store hospitals represents the Adjusted EBITDA margin for those hospitals opened or acquired on or before January 1, 2005 and operated throughout both periods.
 
(d)   Outpatient rehabilitation information for 2005 has been restated to remove the clinics operated by CBIL and sold on March 1, 2006, which is being reported as discontinued operations. Occupational health clinics have been reclassified as managed clinics.
 
(e)   Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by the total number of visits. For purposes of this computation, outpatient rehabilitation clinic revenue does not include managed clinics or contract services revenue.

 


 

V. Key Statistics
(unaudited)
For the Years Ended December 31, 2005 and 2006
                         
                    %
    2005   2006   Change
Specialty Hospitals (a)
                       
 
                       
Number of hospitals — end of period
    101       96       (5.0 )%
 
                       
Net operating revenues (,000)
  $ 1,372,483     $ 1,378,543       0.4 %
 
Number of patient days
    985,025       969,590       (1.6 )%
 
                       
Number of admissions
    39,963       39,668       (0.7 )%
 
                       
Net revenue per patient day (b)
  $ 1,370     $ 1,392       1.6 %
 
                       
Adjusted EBITDA (,000)
  $ 308,144     $ 283,270       (8.1 )%
 
                       
Adjusted EBITDA margin — all hospitals
    22.5 %     20.5 %     (8.9 )%
Adjusted EBITDA margin — same store hospitals (c)
    22.9 %     21.6 %     (5.7 )%
 
                       
Outpatient Rehabilitation (d)
                       
 
                       
Number of clinics — end of period
    608       544       (10.5 )%
 
                       
Net operating revenues (,000)
  $ 480,711     $ 470,339       (2.2 )%
 
                       
Number of visits
    3,308,620       2,972,243       (10.2 )%
 
                       
Revenue per visit (e)
  $ 89     $ 94       5.6 %
 
                       
Adjusted EBITDA (,000)
  $ 65,957     $ 64,823       (1.7 )%
 
                       
Adjusted EBITDA margin
    13.7 %     13.8 %     0.7 %
 
(a)   Specialty hospitals consist of long-term acute care hospitals and acute medical rehabilitation hospitals.
 
(b)   Net revenue per patient day is calculated by dividing specialty hospital patient service revenue by the total number of patient days.
 
(c)   Adjusted EBITDA margin — same store hospitals represents the Adjusted EBITDA margin for those hospitals opened or acquired on or before January 1, 2005 and operated throughout both periods.
 
(d)   Outpatient rehabilitation information for 2005 has been restated to remove the clinics operated by CBIL and sold on March 1, 2006, which is being reported as discontinued operations. Occupational health clinics have been reclassified as managed clinics.
 
(e)   Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by the total number of visits. For purposes of this computation, outpatient rehabilitation clinic revenue does not include managed clinics or contract services revenue.

 


 

VI. Net Income to Adjusted EBITDA Reconciliation
(In thousands)
(unaudited)
For the Three Months and Years Ended December 31, 2005 and 2006
     The following table reconciles net income (loss) to Adjusted EBITDA for Select. Adjusted EBITDA is used by Select to report its segment performance in accordance with SFAS No. 131. Adjusted EBITDA is defined as net income (loss) before interest, income taxes, depreciation and amortization, income from discontinued operations, loss on early retirement of debt, merger related charges, stock compensation expense, long-term incentive compensation, other income, and minority interest. We believe that the presentation of Adjusted EBITDA is important to investors because Adjusted EBITDA is used by management to evaluate financial performance and determine resource allocation for each of our operating units.
     Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles. Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies.
                                                   
                                 
                                 
          Predecessor (1)       Successor (1)     Combined (2)     Successor (1)  
    Successor (1)     Period from       Period from              
    Three Months Ended     January 1       February 25     For the     For the  
    December 31,     through       through     Year Ended     Year Ended  
    2005     2006     February 24, 2005       December 31, 2005     December 31, 2005     December 31, 2006  
               
Net income (loss)
  $ 25,265     $ 32,777     $ (100,251 )     $ 85,575     $ (14,676 )   $ 118,220  
Income (loss) from discontinued operations, net of tax
    295       (2,460 )     (522 )       (3,072 )     (3,594 )     (12,478 )
Income tax expense (benefit)
    17,847       4,811       (59,794 )       56,470       (3,324 )     56,089  
Minority interest
    426       319       330         1,776       2,106       1,414  
Interest expense, net
    23,375       24,118       4,128         82,985       87,113       95,995  
Other income
    (2,360 )     (448 )     (267 )       (3,018 )     (3,285 )     (1,366 )
Loss on early retirement of debt
                42,736               42,736        
Merger related charges
                12,025               12,025        
Stock compensation expense
                                                 
Included in general and administrative
    2,696       888       115,025         10,134       125,159       3,551  
Included in cost of services
    49       57       27,188         178       27,366       231  
Long-term incentive compensation (3)
                        14,453       14,453        
Depreciation and amortization
    9,812       11,713       5,933         37,922       43,855       46,668  
               
Adjusted EBITDA
  $ 77,405     $ 71,775     $ 46,531       $ 283,403     $ 329,934     $ 308,324  
               
Specialty hospitals
  $ 72,833     $ 65,067     $ 44,384       $ 263,760     $ 308,144     $ 283,270  
Outpatient rehabilitation
    13,543       15,903       9,848         56,109       65,957       64,823  
Other (4)
    (8,971 )     (9,195 )     (7,701 )       (36,466 )     (44,167 )     (39,769 )
               
Adjusted EBITDA
  $ 77,405     $ 71,775     $ 46,531       $ 283,403     $ 329,934     $ 308,324  
               
 
(1)   On February 24, 2005, Select Medical Corporation (“Select”) merged with a subsidiary of Select Medical Holdings Corporation (“Holdings”) and became a wholly owned subsidiary of Holdings. Select’s financial position and results of operations prior to the Merger are presented separately in the consolidated financial statements as “Predecessor” financial statements, while the financial position and results of operations following the Merger are presented as “Successor” financial statements. Due to the revaluation of assets as a result of purchase accounting associated with the Merger, the pre-merger financial statements are not comparable with those after the Merger in certain respects.
 
(2)   Although the Predecessor and Successor results are not comparable by definition in certain respects due to the Merger and the resulting revaluation, for ease of comparison, the financial data for the period after the Merger, February 25, 2005 through December 31, 2005 (Successor period), has been added to the financial data for the period from January 1, 2005 through February 24, 2005 (Predecessor period), to arrive at the combined year ended December 31, 2005. As a result of the Merger, interest expense, loss on early retirement of debt, merger related charges, stock compensation expense,long-term incentive compensation, and depreciation and amortization have been impacted.
 
(3)   For the period from February 25 through December 31, 2005, $14.5 million of long-term compensation expense was included in general administrative expense on Select’s consolidated statement of operations.
 
(4)   Other primarily includes Select’s general and administrative costs.

 


 

The following tables reconcile specialty hospital same store information.
                 
    Three Months Ended  
    December 31, 2005     December 31, 2006  
Specialty hospitals net operating revenue
  $ 341,096     $ 328,775  
Less: Specialty hospitals in development, opened or closed after 1/1/05
    9,982       1,817  
 
           
Specialty hospitals same store net operating revenue
  $ 331,114     $ 326,958  
 
           
 
               
Specialty hospitals Adjusted EBITDA
  $ 72,833     $ 65,067  
Less: Specialty hospitals in development, opened or closed after 1/1/05
    1,496       (3,673 )
 
           
Specialty hospitals same store Adjusted EBITDA
  $ 71,337     $ 68,740  
 
           
 
               
All specialty hospitals Adjusted EBITDA margin
    21.4 %     19.8 %
Specialty hospitals same store Adjusted EBITDA margin
    21.5 %     21.0 %
                 
    Year Ended  
    December 31, 2005     December 31, 2006  
Specialty hospitals net operating revenue
  $ 1,372,483     $ 1,378,543  
Less: Specialty hospitals in development, opened or closed after 1/1/05
    49,046       23,764  
 
           
Specialty hospitals same store net operating revenue
  $ 1,323,437     $ 1,354,779  
 
           
 
               
Specialty hospitals Adjusted EBITDA
  $ 308,144     $ 283,270  
Less: Specialty hospitals in development, opened or closed after 1/1/05
    5,404       (9,344 )
 
           
Specialty hospitals same store Adjusted EBITDA
  $ 302,740     $ 292,614  
 
           
 
               
All specialty hospitals Adjusted EBITDA margin
    22.5 %     20.5 %
Specialty hospitals same store Adjusted EBITDA margin
    22.9 %     21.6 %

 


 

VII. Discontinued Operations Income Statement
(In thousands)
(unaudited)
For the Three Months and Years Ended December 31, 2005 and 2006
The following table summarizes the income statement information relating to our discontinued operations of CBIL sold on March 1, 2006:
                                                 
    Successor (1)     Predecessor (1)     Successor (1)     Combined (2)     Successor (1)  
                    Period from     Period from        
                    January 1     February 25        
    For the Three Months     through     through        
    Ended December 31,     February 24,     December 31 ,     For the Year Ended December 31,  
    2005     2006     2005     2005     2005     2006  
Net operating revenues
  $ 18,459     $     $ 10,051     $ 60,161     $ 70,212     $ 12,902  
 
                                               
Costs and expenses:
                                               
Cost of services
    15,098             8,295       48,397       56,692       10,733  
Bad debt expense
    205             73       386       459       87  
Depreciation and amortization
    350             244       1,138       1,382       176  
 
                                   
 
                                               
Income from discontinued operations
    2,806             1,439       10,240       11,679       1,906  
 
                                               
Other expense
    434             267       1,092       1,359        
Gain on sale
                                  (13,950 )
Interest expense (income)
    (452 )           83       (224 )     (141 )     (31 )
 
                                   
 
                                               
Income from discontinued operations before minority interests and income taxes
    2,824             1,089       9,372       10,461       15,887  
 
                                               
Minority interests
    257             139       1,242       1,381       340  
 
                                   
 
                                               
Income from discontinued operations before income taxes
    2,567             950       8,130       9,080       15,547  
 
                                               
Income tax expense (benefit)
    2,862       (2,460 )     428       5,058       5,486       3,069  
 
                                   
 
                                               
Income (loss) from discontinued operations, net of tax
  $ (295 )   $ 2,460     $ 522     $ 3,072     $ 3,594     $ 12,478  
 
                                   
 
(1)   On February 24, 2005, Select Medical Corporation (Select) merged with a subsidiary of Select Medical Holdings Corporation (“Holdings”) and became a wholly owned subsidiary of Holdings. Select’s financial position and results of operations prior to the Merger are presented separately in the consolidated financial statements as “Predecessor” financial statements, while the financial position and results of operations following the Merger are presented as “Successor” financial statements. Due to the revaluation of assets as a result of purchase accounting associated with the Merger, the pre-merger financial statements are not comparable with those after the Merger in certain respects.
 
(2)   Although the Predecessor and Successor results are not comparable by definition in certain respects due to the Merger and the resulting revaluation, for ease of comparison, the financial data for the period after the Merger, February 25, 2005 through December 31, 2005 (Successor period), has been added to the financial data for the period from January 1, 2005 through February 24, 2005 (Predecessor period), to arrive at the combined year ended December 31, 2005. As a result of the Merger, interest expense, loss on early retirement of debt, merger related charges, stock compensation expense, long-term incentive compensation and depreciation and amortization have been impacted.